Momenta Pharmaceuticals, Inc. (MNTA)

Oncology Corporate Profile

Stock Performance

9.3000
-0.0100

HQ Location

675 West Kendall Street
Cambridge, MA 2142

Company Description

Momenta Pharmaceuticals is a biotechnology company specializing in the detailed structural and functional analysis of complex drugs and is headquartered in Cambridge, MA. Momenta is applying its technology to the development of generic versions of complex drugs, biosimilar and potentially interchangeable biologics, and to the discovery and development of novel therapeutics for oncology and autoimmune indications.

Website: http://www.momentapharma.com/

This company does not have any commercial products

This company does not have any pipeline products

Pipeline image

Source


http://www.momentapharma.com/

Recent News Headlines

Lifshitz & Miller LLP Announces Investigation of Aratana Therapeutics, Inc., FXCM Inc., Innocoll Holdings plc, Momenta Pharmaceuticals, Inc., Omnicom Group Inc., Perrigo Company plc, Santander Consumer USA Holdings Inc. and The Interpublic

3/24/2017 11:00 pm

[PR Newswire] - NEW YORK, March 24, 2017 /PRNewswire/ -- Aratana Therapeutics, Inc. (PETX) Lifshitz & Miller announces investigation on behalf of PETX investors concerning PETX's statements about the commercial viability ...

INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving the Board of Momenta Pharmaceuticals, Inc. -- MNTA

3/7/2017 04:00 pm

[PR Newswire] - NEW YORK, March 7, 2017 /PRNewswire/ -- Levi & Korsinsky announces it has commenced an investigation of Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA). On February 17, 2017, Momenta announced that a contracted ...

Momenta Pharmaceuticals to Webcast Presentation at the Cowen and Company 37th Annual Health Care Conference

2/28/2017 01:00 pm

[GlobeNewswire] - CAMBRIDGE, Mass., Feb. 28, 2017-- Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will present at the ...

SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Momenta Pharmaceuticals, Inc. and Advises Investors with Losses to Contact the Firm

2/24/2017 04:02 pm

[Business Wire] - Goldberg Law PC announces that it is investigating Momenta Pharmaceuticals, Inc. concerning possible violations of federal securities laws.

Glancy Prongay & Murray LLP Commences Investigation on Behalf of Momenta Pharmaceuticals, Inc. Investors

2/24/2017 03:03 pm

[Business Wire] - Glancy Prongay & Murray LLP announces an investigation on behalf of Momenta Pharmaceuticals, Inc. investors concerning the Company and its officers’ possible violations of federal securities laws.

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Momenta Pharmaceuticals, Inc., and Encourages Investors to Contact the Firm

2/22/2017 07:03 pm

[Business Wire] - Khang & Khang LLP announces that it is investigating claims against Momenta Pharmaceuticals, Inc. concerning possible violations of federal securities laws.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving the Board of Momenta Pharmaceuticals, Inc. -- MNTA

2/22/2017 05:01 pm

[Business Wire] - Levi & Korsinsky announces it has commenced an investigation of Momenta Pharmaceuticals, Inc. . On February 17, 2017, Momenta announced that a contracted Pfizer facility used to manufacture the Company's Glatopa product had received a warning letter from the U.S.

INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Momenta Pharmaceuticals, Inc. Investors

2/22/2017 03:03 pm

[Business Wire] - Law Offices of Howard G. Smith announces an investigation on behalf of Momenta Pharmaceuticals, Inc. investors concerning the Company and its officers’ possible violations of federal securities laws.

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Momenta Pharmaceuticals, Inc. (MNTA)

2/22/2017 03:01 pm

[PR Newswire] - NEW YORK, Feb. 22, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Momenta Pharmaceuticals, Inc. ("Momenta" ...